170

Hepatobiliary&Pancreas Surgery
Focuses on the health of liver, bile, and pancreatic organs.
Sub Categories on Hepatobiliary&Pancreas Surgery
Latest Articles
How protein protects against fatty liver

How protein protects against fatty liver

by Deutsches Zentrum fuer Diabetesforschung DZDMicroscopic images of liver biopsies of three individuals with different degrees of liver fat accumulation. Credit: DIfENon-alcoholic fatty liver disease

How protein protects against fatty liver

by Deutsches Zentrum fuer Diabetesforschung DZDMicroscopic images of liver biopsies of three individuals with different degrees of liver fat accumulation. Credit: DIfENon-alcoholic fatty liver disease
Liver function tests can ID occult disorders in systemic sclerosis

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli
How to Choose Good Foods for Your Liver

How to Choose Good Foods for Your Liver

How to Choose Good Foods for Your LiverSupport liver health with these fruits, vegetables, and beveragesByLauren Panoff, MPH, RDPublished on August 08, 2023Medically reviewed by&nbsp

How to Choose Good Foods for Your Liver

How to Choose Good Foods for Your LiverSupport liver health with these fruits, vegetables, and beveragesByLauren Panoff, MPH, RDPublished on August 08, 2023Medically reviewed by&nbsp
Novel pathway could lead to potential treatment for metabolic liver disease

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103
Norovirus study shows how bile acids in breast milk affect newborn gut health

Norovirus study shows how bile acids in breast milk affect newborn gut health

by Jiayu Liang,University of FloridaGraphical abstract. Credit:Cell Host & Microbe(2024). DOI: 10.1016/j.chom.2024.08.003A University of Florida researcher has compiled the first

Norovirus study shows how bile acids in breast milk affect newborn gut health

by Jiayu Liang,University of FloridaGraphical abstract. Credit:Cell Host & Microbe(2024). DOI: 10.1016/j.chom.2024.08.003A University of Florida researcher has compiled the first
Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver DiseaseByKelly BurchUpdated on October 17, 2022Medically reviewed byRobert Burakoff, MDYourliveris one of the largest organs in you

Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver DiseaseByKelly BurchUpdated on October 17, 2022Medically reviewed byRobert Burakoff, MDYourliveris one of the largest organs in you
Study provides basis for personalized hepatitis C aftercare

Study provides basis for personalized hepatitis C aftercare

by Medical University of ViennaCredit: AI-generated imageEven after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in ad

Study provides basis for personalized hepatitis C aftercare

by Medical University of ViennaCredit: AI-generated imageEven after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in ad
Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi
Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes
Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

by Xia & He Publishing Inc.Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve
Scientists find omega-3 lysolipids may prevent fatty liver disease

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by